← Back to Search

Sleep Disturbance Analysis for Gastrointestinal Cancer

N/A

Waitlist Available

Led By Sriram Yennu

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with an expected hospital stay of at least 72 hours

Adult GI Cancer patients admitted for elective gastrointestinal surgery

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial is designed to determine sleep disturbance and its types among patients with gastrointestinal cancers during the perioperative period by using the Richard Campbell sleep questionnaire.

Who is the study for?

This trial is for adult patients with gastrointestinal cancers who are scheduled for elective surgery and will be in the hospital for at least 3 days. Participants must be able to read and speak English and have internet access or a mobile device compatible with FitBit.Check my eligibility

What is being tested?

The study aims to measure sleep disturbances in GI cancer patients during their hospital stay using the Richard Campbell Sleep Questionnaire. Patients will complete this survey daily before and after surgery to assess changes in their sleep quality.See study design

What are the potential side effects?

Since this trial involves completing questionnaires rather than testing a drug, there are no direct side effects from interventions. However, participants may experience discomfort or stress related to reflecting on their sleep patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I will be in the hospital for at least 3 days.

Select...

I am an adult with GI cancer scheduled for elective GI surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Correlating the sleep disturbance and its types among patients with gastrointestinal cancers.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Sleep DisturbancesExperimental Treatment1 Intervention

Difficulty Sleeping

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,967 Previous Clinical Trials

1,804,602 Total Patients Enrolled

11 Trials studying Gastrointestinal Cancers

1,010 Patients Enrolled for Gastrointestinal Cancers

American Cancer Society, Inc.OTHER

224 Previous Clinical Trials

110,255 Total Patients Enrolled

Sriram YennuPrincipal InvestigatorM.D. Anderson Cancer Center

12 Previous Clinical Trials

1,357 Total Patients Enrolled

Media Library

Sleep Disturbances Clinical Trial Eligibility Overview. Trial Name: NCT05044312 — N/A

Gastrointestinal Cancers Research Study Groups: Sleep Disturbances

Gastrointestinal Cancers Clinical Trial 2023: Sleep Disturbances Highlights & Side Effects. Trial Name: NCT05044312 — N/A

Sleep Disturbances 2023 Treatment Timeline for Medical Study. Trial Name: NCT05044312 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still space available to enrol in this experiment?

"Clinicaltrials.gov reveals that this medical trial--initially published on September 30th 2022 and last modified on August 25th of the same year--is not presently accepting patients. However, 281 other clinical studies are actively recruiting participants as we speak."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis

2024. "Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05044312.

All > Sleep Disorders